Developing a practical resource to improve the ethical standing of gene therapy trials

By Rosie Munday, Hugh Davies and Stephanie Jones with Oxford “A” Health Research Authority Research Ethics Committee Oxford “A” NHS REC is one of the four UK Research Ethics Committees flagged to review gene therapy proposals. Following the philosopher Mary Warnock’s sage advice “I do not believe you can make moral judgements unless, as far […]

Read More…

Medical assistance in dying—is there a case for including persons with mental illness?

By Nicholas Delva, Anees Bahji Over the last couple of decades, medical assistance in dying (MAiD) has become legal in a few developed countries. Developments in this area have been primarily driven by patients, with general support from the population. Governments have been cautious in the development of legislation, which is not surprising given that […]

Read More…

The carbon emissions of prescribing practices

By Cristina Richie. Health care has a carbon footprint, which contributes to climate change and climate change health hazards, like severe weather, flooding, tornadoes, drought, and anxiety. Carbon emissions come from health care structures and health care activities. Health care structures like hospitals and clinics rely on high-carbon use building materials, heat and cooling, water […]

Read More…

Call for papers: Operationalising Fairness in Medical Algorithms

From the BMJ Health & Care Informatics: This special issue aims to bring together the growing community of healthcare practitioners, social scientists, policymakers, engineers and computer scientists to design and discuss practical solutions to address algorithmic fairness and accountability. We are inviting papers that explore ways to reduce machine bias in healthcare or create algorithms that […]

Read More…

Bell v Tavistock and Portman NHS Foundation Trust: Considering the potential impact on children’s consent to all medical treatment?

By Rebecca Limb and Liz James On 1st December 2020, the Tavistock judgment was published. The legal issue concerning the court was identifying the circumstances where a child, under the age of 18 diagnosed with Gender Dysphoria (GD), is competent to give valid consent to the administration of puberty blockers (PB). The judgment has made […]

Read More…